.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Genomics in Drug Discovery and Development
Dimitri Semizarov
€ 181.48
FREE Delivery in Ireland
Description for Genomics in Drug Discovery and Development
Hardcover. Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. Num Pages: 480 pages, Illustrations. BIC Classification: TCBG; TDCW. Category: (P) Professional & Vocational. Dimension: 242 x 161 x 28. Weight in Grams: 840.
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
Product Details
Format
Hardback
Publication date
2008
Publisher
John Wiley and Sons Ltd United Kingdom
Number of pages
480
Condition
New
Number of Pages
496
Place of Publication
New York, United States
ISBN
9780470096048
SKU
V9780470096048
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50
About Dimitri Semizarov
Dimitri Semizarov, PhD, is a Senior Group Leader in the Cancer Research Department of Abbott Laboratories' Global Pharmaceutical R&D. Dr. Semizarov leads cancer genomics research at Abbott, applying genomics technologies to enable personalization of cancer therapy. He is author or coauthor of more than twenty scientific articles and eight patent applications, as well as three book chapters (including two chapters ... Read more
Reviews for Genomics in Drug Discovery and Development
?This book is highly recommended to active researchers in genomics and to the comparative and veterinary clinician or researchers looking for a focused review of the emerging discipline.? (The Veterinary Journal , August 2009) ?Overall, it provides excellent, up-to-date coverage of the application of genomics in drug development.? (Doody's Reviews, June 2009)